课题基金 / 基金详情

RISK MARKERS FOR DEMENTIA AFTER STROKE

RISK MARKERS FOR DEMENTIA AFTER STROKE
中风后痴呆症的风险标志
批准号:
6735674
负责人:
DAVID L NYENHUIS
金额:
$75.29万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-01 至 2006-04-30

项目摘要

项目成果

DAVID L NYENHUIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Applicant's Abstract): Dementia and cognitive impairment associated with stroke are an important but enigmatic public health problem. As many stroke patients are elderly, concomitant pathophysiologic mechanisms may play a role in the genesis of their dementia. Now, novel quantitative MRI imaging technology is available as a potentially powerful in vivo research tool that may identify factors that contribute to dementia and cognitive impairment in patients with stroke. The major aim of this proposal is to identify risk markers such as hippocampal and entorhinal cortex volume, white matter dysfunction, stroke volume, and generalized brain volume by quantitative MRI technology that may contribute to dementia and cognitive impairment in stroke patients. The applicants propose to use a new technology of quantitative MRI analysis, diffusion tensor scanning, to study diseased white matter of the brain. The proposed analysis will take into account MRI and other factors that may be important in the genesis of dementia after stroke by case-control methodology among ischemic stroke patients who do or do not develop dementia. The applicants propose to study the contribution of MRI markers of Alzheimer's disease (AD) in stroke patients. In those stroke patients who do not show quantitative MRI markers for AD, it may be possible to begin to define 'vascular dementia.' The findings will be validated by neuropathologic correlation among patients who come to autopsy. By defining the role of quantitative MRI analysis in dementia patients after stroke, the applicants propose to clarify the concept of 'vascular dementia.' They state that refinement in our knowledge of mechanisms and causes for dementia in stroke patients may lead to an improvement in prevention and treatment strategies.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Baseline differences between vascular cognitive impairment no dementia reverters and non-reverters.
血管性认知障碍无痴呆恢复者和非痴呆恢复者之间的基线差异。
DOI: 10.1136/jnnp.2007.137554
发表时间: 2008
期刊: Journal of neurology, neurosurgery, and psychiatry
影响因子: --
作者: [Williamson,JB, Nyenhuis,DL, Pedelty,L, Byrd,S, Jhaveri,M, Wang,C, deToledo-Morrell,L, Sripathirathan,K, Gorelick,P]
通讯作者: Gorelick,P
Regional differences in relationships between apparent white matter integrity, cognition and mood in patients with ischemic stroke.
缺血性中风患者表观白质完整性、认知和情绪之间关系的区域差异。
DOI: 10.1080/13803390903427406
发表时间: 2010
期刊: Journal of clinical and experimental neuropsychology
影响因子: 2.2
作者: [Williamson,John, Nyenhuis,David, Stebbins,GlennT, Lamb,Damon, Simkus,Vaidas, Sripathirathan,Kumar, Wang,Changsheng, deToledo-Morrell,Leyla, Gorelick,Philip]
通讯作者: Gorelick,Philip
DOI: 10.1016/j.autneu.2010.03.009
发表时间: 2010-08-25
期刊: Autonomic neuroscience : basic & clinical
影响因子: --
作者: [Williamson JB, Lewis G, Grippo AJ, Lamb D, Harden E, Handleman M, Lebow J, Carter CS, Porges SW]
通讯作者: Porges SW
DOI: 10.1111/j.1469-8986.2012.01467.x
发表时间: 2012
期刊: Psychophysiology
影响因子: 3.7
作者: [Williamson,JB, Lewis,GF, Nyenhuis,DL, Stebbins,GT, Murphy,C, Handelman,M, Harden,E, Heilman,KM, Gorelick,PB, Porges,SW]
通讯作者: Porges,SW
Validation of the NINDS VCI Neuropsychology Protocols
  • 批准号:
    7667160
  • 项目类别:
  • 资助金额:
    $50.95万
  • 财政年份:
    2007
  • 负责人:
    DAVID L NYENHUIS
  • 依托单位:
Validation of the NINDS VCI Neuropsychology Protocols
  • 批准号:
    7479674
  • 项目类别:
  • 资助金额:
    $50.84万
  • 财政年份:
    2007
  • 负责人:
    DAVID L NYENHUIS
  • 依托单位:
Validation of the NINDS VCI Neuropsychology Protocols
  • 批准号:
    7187273
  • 项目类别:
  • 资助金额:
    $46.49万
  • 财政年份:
    2007
  • 负责人:
    DAVID L NYENHUIS
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究